sk&f-38393 and arginine

sk&f-38393 has been researched along with arginine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Starr, BS; Starr, MS1
Kayir, H; Uzbay, IT1
Ijames, SG; Lysle, DT; Saurer, TB1

Other Studies

4 other study(ies) available for sk&f-38393 and arginine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide?
    European journal of pharmacology, 1995, Jan-16, Volume: 272, Issue:2-3

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine; Male; Mice; Motor Activity; Nitric Oxide; Nitroarginine; Phenethylamines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Reserpine

1995
Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2003, Volume: 367, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Ethanol; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes

2003
Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Journal of neuroimmunology, 2006, Volume: 177, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Arginine; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Immune Tolerance; Killer Cells, Natural; Male; Morphine; Morphine Dependence; Narcotics; Neuroimmunomodulation; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Inbred Lew; Receptors, Dopamine D1; Receptors, Neuropeptide Y; Spleen; Sympathetic Nervous System

2006